• Vertex Pharmaceuticals (VRTX) selling rights to telaprevir. [BusinessWire]

• Bioniche gets $20M upfront from Endo for bladder cancer drug. [Canadian Press]

• Pfizer dumps SF, but embraces Ireland. [Pharmafocus]

• Scrapped! Sciele axes Victory deal. [BizJournals]

• P&G: What’s a social network when you can’t socialize? [PharmaMarketing]

• Not looking good for Big Pharma. [Reuters]

• It’s over! Sermo and the AMA are done! [HealthLeadersMedia]

• TV vs. pharma DTC… [WSJ Health Blog]

• The push for online drugs from Canada…yay!!! [WSJ]

• Finally, Eli Lilly & Co. and Daiichi Sankyo get FDA approval for anticlotting drug prasugrel (Effient). Despite getting a black box warning, the drug is expected to achieve blockbuster status. [Bloomberg]

Anonymous Tip? Comments? Contact us: hr AT iguanabio DOT com

Related Posts